Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on BILFINGER SE. We currently have 5 research reports from 2 professional analysts.
Frequency of research reports
Research reports on
Rebirth of the Phoenix? Compelling new strategy but 2020 targets look ambitious
15 Feb 17
Key information: • EBIT at €-231m versus consensus of €-138m. • Adjusted EBITA at €15m versus loss of €23m in FY2015. • Adjusted EBITA margin at 0.4%. • Adjusted net income at -114m versus consensus of €60m. • Bilfinger targets an adjusted EBITA margin of c.5% in 2020. • Dividend higher than expected and share buy-back announced. • Bilfinger CEO said that it expects the company to be cash positive by year end. • Cash flow from operating activities at €-224m versus €39m in 2015.
BILL(finger): unsound 9m performance, messy conference call, higher restructuring BILL(finger)
10 Nov 16
Key information: • Adjusted EBITA and adjusted net profit from continuing operations improved compared to previous year. • Adjusted EBITA improves to €21m despite a significant decline in volume. • Order backlog declined by 19% in total (organically -15%). • Over the 9m period, Bilfinger has burnt close to €250m of cash. • Power division: orders received decreased by 30%. • Power division: order backlog decreased by 40% (organically -37%). • Power division: EBITA of -€1m, but output volume continues to decline significantly. • Power division: falling orders received will, however, lead to decreasing utilisation in several business units. • Industrial division: orders received increased by 3%. • Industrial division: order backlog was 9% below the prior year figure (organically -4%). • Industrial division: decrease in EBITA but margin of 5.1%, slightly above the previous year with significantly lower output volume. • Capital Markets Day on 14 February 2017: Presentation of strategy and implementation plan.
A lot of work ahead!
07 Nov 16
Business Historically, Bilfinger was a construction company with 95% of its revenues stemming from this business in 2000 and only 5% from services. As a result of numerous acquisitions (in the Industrial, Power and Building & Facility field) and disposals (of Concession, Construction and more recently the whole Building & Facility division), the company is no longer a construction company but a provider of services for industrial plants (and power plants: the Power division is up for sale on a unit basis). Indeed, after the divestment of the Building & Facility division and the strategic decision to focus on the Industrial division, Bilfinger is a leading international industrial services provider. The company delivers customised engineering and services to customers in the process industry. Bilfinger enhances the efficiency of assets, increases their availability and reduces maintenance costs. The portfolio covers the entire value chain: from consulting, engineering, fabrication and installation through to comprehensive maintenance concepts and their implementation including turnarounds. Bilfinger stands for the highest standards of quality and thus meets the strict requirements of customers active in the chemical (20%), energy (29%), oil & gas sectors (31%) and pharmaceutical sectors (4%) as well as other sectors (16%). The company generates an annual output volume of more than €4bn with about 40,000 employees. Bilfinger has a c.€1.5bn market cap. Recommendation and upside We initiate Bilfinger with a sell recommendation and 15% downside. Main earnings drivers: • Restructuring: as the restructuring goes on, financial performance should be improved. • A recovery in the oil and gas sector: this would have a positive effect on the top line and hence the bottom line. Need to know Bilfinger has suffered in the past two years from turmoil in the energy and oil & gas sectors to which many of its important customers belong, resulting in six profit warnings within two years. The first three warnings, which took place between June and September 2014, were the result of the former management not appreciating the gravity of the situation, being too optimistic and trying to stay on board. As a result of the first two profit warnings the management in place at that time led by CEO Roland Koch was fired. Investor trust was also hit by the abrupt departure of Per Utnegaard although it now seems that the fit with the company had not been ideal. Bilfinger in effect acts as a private equity company by buying and selling engineering-related businesses. Call it a de facto specialist fund. In our view, some of these transactions may have been intended to delay or mask the unwinding of aggressive past accounting practices. The company’s poor earnings quality may have been masked by acquiring companies and allocating more to intangibles, notably goodwill, in order to provide room for future earnings growth through lower-than-required depreciation expenses. However, as the power market has collapsed the goodwill impairment has underlined the fact that some of the profits recognised in the past may have been borrowed from the future, which is now the present. The goodwill impairment also shows that Bilfinger paid too much for these businesses by buying them at the top of the cycle, which is not great for a private equity type business. In our view, the sale of the Building and Facility division, the company’s most profitable division, was driven by the need to avoid tapping the equity market and the company’s limited access to the debt market with pressure from bankers due to the rapid deterioration in the unsellable Power division. As a result of the sale of the Building & Facility division, the two remaining divisions, namely Industrial and Power, are respectively unmanageable and unsellable under current conditions. The Industrial division needs to be extensively restructured, which means high restructuring costs, and the Power division needs to be broken down into three baskets, namely what can be sold, what can be restructured and what needs to be shut down, implying additional restructuring costs. Finally, if the proceeds from the sale of the Building and Facility division are not fully absorbed in this restructuring process they will have to be reallocated to new acquisitions, which means transaction costs. Overall, we are not sure the company can exit this process without destroying additional shareholder value in the medium term. History tells us that it is not that easy to rebuild a sound business from the scraps of an inefficient one. Next trigger Owing to this legacy of missed targets and following several months of strategic review, the new CEO Thomas Blade will need to present a set of fairly conservative targets to give the market some form of anchor. In a sense, Bilfinger has learned from its mistakes meaning that we see some potential for upside risk linked to the new targets expected to be announced imminently. We nonetheless prefer to await their announcement before taking a more positive view on the stock as these targets may fall short of market expectations.
Debt & renewables dominate
09 Jan 14
A total of £3.1bn was raised in the funds sector in the fourth quarter of 2013, exceeding total funds raised for the whole of 2012 (£2.7bn). The alternative asset and income theme continued to dominate, with most successful vehicles offering yields in excess of 5%.
Summary of fund raising in the sector
03 Oct 13
Three successful fund raises were announced this morning, two IPOs and one placing: - DP Aircraft I (Dr Peters) – IPO at £c70m with Canaccord (oversubscribed). - Chenavari Capital Solutions Fund (Asset Backed Securities) – IPO at c£130m with Dexion (50% of the target). - John Laing Infrastructure (JLIF) – £243m under a placing (the maximum) with JPM Cazenove. Next to announce are the two C-Shares from ABAA (Monday) and BRNA (Thursday). Updated Q4 fund raising table follows, almost at £3bn now at the top end of the targets.
20 Feb 17
Hayward Tyler Group* (HAYT): Trading update and financial position (CORP) | Petra Diamonds (PDL): Interim results (BUY) | Gemfields* (GEM): Interim results (CORP) | Premaitha Health* (NIPT): Middle East momentum (CORP) | Sound Energy (SOU): Acquisition update and TE-8 well spud (HOLD) | Proactis* (PHD): Interim trading on track (CORP) | 7digital* (7DIG): Automotive contract win (CORP)
The Slide Rule
12 Jan 17
What is The Slide Rule? The Slide Rule has been designed to dramatically simplify the identification of the best companies in the UK small/mid-cap sector by making a quantitative assessment of the relative potential of each company. At its core, The Slide Rule aims to identify those companies that create genuine shareholder value through strong returns on capital and solid growth, but also present a value opportunity with the potential tailwind of earnings momentum. Companies are assessed within a Quality, Value, Growth and Momentum (QVGM) framework.
21 Feb 17
Lighthouse Group* (LGT): Middle Britain growth (CORP) | Utilitywise* (UTW): Double-digit sales growth (CORP) | Trakm8* (TRAK): Earnings expectations cut again (CORP) | dotDigital* (DOTC): Myriad growth opportunities (CORP) | Artilium* (ARTA): Five-year Telenet deal secured and prepaid (CORP) | Netcall* (NET): Cloud investment pays off (CORP)
N+1 Singer - Small-cap quantitative research - New quality style screen + 11 quality focus stocks
09 Feb 17
We introduce our fourth and final style screen representing “quality”. This screens for stocks with the best combination of high returns on capital/equity, EBIT margins and operating cash-flow conversion rates. These criteria should help us monitor how strong underlying returns translate into share price performance over time and under varying market conditions. The screen selects the “best” 25 stocks from our universe of just over 500 stocks and, as usual, we focus on a shorter list of stocks we cover or otherwise know and believe to be particularly interesting. We provide brief investment summaries on these focus stocks on pages 4 – 9. We will monitor performance and refresh the screen in approximately 3-4 months time.
N+1 Singer - Morning Song 22-02-2017
22 Feb 17
CORETX (COR LN) Contract wins and new Lifestyle facility | Gooch & Housego (GHH LN) Solid Q1 trading plus earnings enhancing acquisition of StingRay Optics | NCC Group (NCC LN) Further issues in Assurance | PCI-PAL (PCIP LN) Strong H1 underpins positive outlook | UBM (UBM LN) Results | Verona Pharma (VRP LN) Phase IIa RPL554 add-on trial to tiotropium commenced
16 Feb 17
In its Q317 trading update management confirmed that Trifast remains on track to achieve another record full year performance. The shares have continued to perform strongly, rising by 43% since the interim results in October. The progress appears warranted by the FX enhanced trading performance, which has enabled us to modestly increase our FY17 and FY18 forecasts. The shares are now trading on an FY18e P/E of 17.6x.